Evidence map›Paper›PMID 40112159›Full record

ArticleDiabetes2025

An Essential Role of IER3IP1 in β-Cell Development and Proinsulin Trafficking.

Wenli Feng, Peter Arvan, Ming Liu

Abstract readEditorialComment
In one paragraph

Article in Diabetes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Wenli FengDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China.
Peter ArvanDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, MI.ORCID 0000-0002-4007-8799
Ming LiuDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China.ORCID 0000-0003-2665-4072

Funding

Proinsulin Trafficking for Insulin BiosynthesisR01DK048280 · NIDDK · YESHIVA UNIVERSITY · PI ARVAN, PETER · 1994 to 2024
$10.5M
National Key Research and Development Program of China 2022YFE0131400National Natural Science Foundation of China 82220108014NIDDK NIH HHS R01 DK048280Tianjin Key Medical Discipline (Specialty) Construction Project TJYXZDXK-030ATianjin Medical University Clinical Special Disease Research Center - Neuroendocrine Tumor Clinical Special Disease Research CenterTianjin Medical University General Hospital Clinical Research Program 22ZYYLCZD02Tianjin Municipal Health Commission TJWJ2021ZD001Tianjin Municipal Science and Technology Committee 23JCQNJC00680
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40112159
PMCPMC12862348

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.